BIO-TECHNE Corp (TECH)
Data as of , from SEC Form 4 filings.
See up to 3 months of TECH. The 7-day demo opens the 1M and 3M ranges and puts TECH on your watchlist.
Start 7-day demoLatest TECH insider trades
Amy E. Herr - DirectorOpen-market sale$320K- Amy E. Herr - DirectorOpen-market sale$117K
- John L. Higgins
About BIO-TECHNE Corp (TECH)
BIO-TECHNE Corp is an SEC registrant, filing under CIK 0000842023, classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
TECH Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 11 | 302,815 | |
| Option exercise | 36 | 354,846 | |
| Tax withholding / forfeiture | 11 | 111,785 | |
TECH insider transactions (Form 4)
9666 Form 4 filings on record, the earliest from Oct 28, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Matthew McManus - Officer | Option exercise | Common Stock | 4,621 | $0.00 | - | |
| Matthew McManus - Officer | Tax withholding / forfeiture | Common Stock | 1,665 | $64.09 | $107K | |
| Matthew McManus - Officer | Option exercise | Restricted Stock Units | 4,621 | $0.00 | - | |
| Kim Kelderman - Officer | Tax withholding / forfeiture | Common Stock | 2,303 | $62.57 | $144K | |
| James Hippel - Officer | Option exercise | Restricted Stock Units | 13,159 | $0.00 | - | |
| James Hippel - Officer | Option exercise | Restricted Stock Units | 11,545 | $0.00 | - | |
| James Hippel - Officer | Option exercise | Common Stock | 13,159 | $0.00 | - | |
| James Hippel - Officer | Option exercise | Common Stock | 11,545 | $0.00 | - | |
| James Hippel - Officer | Tax withholding / forfeiture | Common Stock | 11,865 | $62.57 | $742K | |
 William Geist - Officer | Option exercise | Common Stock | 9,911 | $0.00 | - | |
| William Geist - Officer | Tax withholding / forfeiture | Common Stock | 4,520 | $62.57 | $283K | |
| William Geist - Officer | Option exercise | Restricted Stock Units | 9,911 | $0.00 | - | |
| Julie L. Bushman - Director | Grant or award | Common Stock | 1,640 | $0.00 | - | |
| Julie L. Bushman - Director | Grant or award | Stock Options (Right to Buy) | 3,777 | $0.00 | - | |
| Joseph D. Keegan - Director | Grant or award | Common Stock | 1,640 | $0.00 | - | |
| Joseph D. Keegan - Director | Grant or award | Stock Options (Right to Buy) | 3,777 | $0.00 | - | |
| John L. Higgins - Director | Grant or award | Common Stock | 1,640 | $0.00 | - | |
| John L. Higgins - Director | Grant or award | Stock Options (Right to Buy) | 3,777 | $0.00 | - | |
| Alpna Seth - Director | Grant or award | Common Stock | 1,640 | $0.00 | - | |
| Alpna Seth - Director | Grant or award | Stock Options (Right to Buy) | 3,777 | $0.00 | - | |
| Amy E. Herr - Director | Grant or award | Common Stock | 1,640 | $0.00 | - | |
| Amy E. Herr - Director | Grant or award | Stock Option (Right to Buy) | 3,777 | $0.00 | - | |
| Judith V. Klimovsky - Director | Grant or award | Common Stock | 1,640 | $0.00 | - | |
| Judith V. Klimovsky - Director | Grant or award | Stock Option (Right to Buy) | 3,777 | $0.00 | - | |
| Rupert Vessey - Director | Grant or award | Common Stock | 1,640 | $0.00 | - | |
| Rupert Vessey - Director | Grant or award | Stock Options (Right to Buy) | 3,777 | $0.00 | - | |
 Robert V. Baumgartner - Director | Grant or award | Common Stock | 1,640 | $0.00 | - | |
| Robert V. Baumgartner - Director | Grant or award | Stock Options (Right to Buy) | 3,777 | $0.00 | - | |
| Roeland Nusse - Director | Option exercise | Common Stock | 17,040 | $21.84 | $372K | |
| Roeland Nusse - Director | Open-market sale | Common Stock | 17,040 | $56.36 | $960K | |
| Roeland Nusse - Director | Option exercise | Stock Options (Right to Buy) | 17,040 | $0.00 | - | |
| Robert V. Baumgartner - Director | Option exercise | Common Stock | 17,040 | $21.84 | $372K | |
| Robert V. Baumgartner - Director | Open-market sale | Common Stock | 17,040 | $56.21 | $958K | |
| Robert V. Baumgartner - Director | Option exercise | Stock Options (Right to Buy) | 17,040 | $0.00 | - | |
| Amy E. Herr - Director | Option exercise | Common Stock | 279 | $0.00 | - | |
| Amy E. Herr - Director | Tax withholding / forfeiture | Common Stock | 101 | $53.60 | $5K | |
| Amy E. Herr - Director | Option exercise | Restricted Stock Units | 119 | $0.00 | - | |
| Amy E. Herr - Director | Option exercise | Restricted Stock Units | 160 | $0.00 | - | |
| Amy E. Herr - Director | Grant or award | Restricted Stock Units | 932 | $0.00 | - | |
| Amy E. Herr - Director | Grant or award | Stock Option (Right to Buy) | 2,735 | $0.00 | - | |
| Shane Bohnen - Officer | Option exercise | Common Stock | 1,718 | $0.00 | - | |
| Shane Bohnen - Officer | Tax withholding / forfeiture | Common Stock | 527 | $53.60 | $28K | |
| Shane Bohnen - Officer | Option exercise | Restricted Stock Units | 50 | $0.00 | - | |
| Shane Bohnen - Officer | Option exercise | Restricted Stock Units | 1,668 | $0.00 | - | |
| Shane Bohnen - Officer | Grant or award | Performance Restricted Stock Units | 13,992 | $0.00 | - | |
| Shane Bohnen - Officer | Grant or award | Restricted Stock Units | 6,996 | $0.00 | - | |
| Shane Bohnen - Officer | Grant or award | Stock Option (Right to Buy) | 17,897 | $0.00 | - | |
| Matthew McManus - Officer | Option exercise | Common Stock | 2,637 | $0.00 | - | |
| Matthew McManus - Officer | Tax withholding / forfeiture | Common Stock | 880 | $53.60 | $47K | |
| Matthew McManus - Officer | Option exercise | Restricted Stock Units | 2,637 | $0.00 | - | |
| Matthew McManus - Officer | Grant or award | Performance Restricted Stock Units | 19,243 | $0.00 | - | |
| Matthew McManus - Officer | Grant or award | Restricted Stock Units | 9,622 | $0.00 | - | |
| Matthew McManus - Officer | Grant or award | Stock Option (Right to Buy) | 24,614 | $0.00 | - | |
| William Geist - Officer | Option exercise | Common Stock | 2,623 | $0.00 | - | |
| William Geist - Officer | Tax withholding / forfeiture | Common Stock | 803 | $53.60 | $43K | |
| William Geist - Officer | Option exercise | Restricted Stock Units | 2,623 | $0.00 | - | |
| William Geist - Officer | Grant or award | Performance Restricted Stock Units | 19,355 | $0.00 | - | |
| William Geist - Officer | Grant or award | Restricted Stock Units | 9,678 | $0.00 | - | |
| William Geist - Officer | Grant or award | Stock Options (Right to Buy) | 24,758 | $0.00 | - | |
| Kim Kelderman - Officer | Option exercise | Common Stock | 8,543 | $0.00 | - | |
| Kim Kelderman - Officer | Tax withholding / forfeiture | Common Stock | 4,305 | $53.60 | $231K | |
| Kim Kelderman - Officer | Option exercise | Restricted Stock Units | 8,543 | $0.00 | - | |
| Kim Kelderman - Officer | Grant or award | Performance Restricted Stock Units | 70,708 | $0.00 | - | |
| Kim Kelderman - Officer | Grant or award | Restricted Stock Units | 35,354 | $0.00 | - | |
| Kim Kelderman - Officer | Grant or award | Stock Options (Right to Buy) | 90,441 | $0.00 | - | |
| James Hippel - Officer | Option exercise | Common Stock | 4,010 | $0.00 | - | |
| James Hippel - Officer | Tax withholding / forfeiture | Common Stock | 1,926 | $53.60 | $103K | |
| James Hippel - Officer | Option exercise | Restricted Stock Units | 4,010 | $0.00 | - | |
| James Hippel - Officer | Grant or award | Performance Restricted Stock Units | 29,420 | $0.00 | - | |
| James Hippel - Officer | Grant or award | Restricted Stock Units | 14,710 | $0.00 | - | |
| James Hippel - Officer | Grant or award | Stock Options (Right to Buy) | 37,632 | $0.00 | - | |
| John L. Higgins - Director | Option exercise | Common Stock | 5,040 | $21.84 | $110K | |
| John L. Higgins - Director | Option exercise | Stock Option (Right to Buy) | 5,040 | $0.00 | - | |
| James Hippel - Officer | Option exercise | Common Stock | 168,620 | $44.33 | $7.47M | |
| James Hippel - Officer | Tax withholding / forfeiture | Common Stock | 147,431 | $58.55 | $8.63M | |
| James Hippel - Officer | Option exercise | Stock Options (Right to Buy) | 168,620 | $0.00 | - | |
| Kim Kelderman - Officer | Option exercise | Common Stock | 48,176 | $44.33 | $2.14M | |
| Kim Kelderman - Officer | Tax withholding / forfeiture | Common Stock | 43,649 | $53.12 | $2.32M | |
| Kim Kelderman - Officer | Option exercise | Stock Option (Right to Buy) | 48,176 | $0.00 | - | |
| Kim Kelderman - Officer | Option exercise | Common Stock | 36,132 | $44.33 | $1.60M | |
| Kim Kelderman - Officer | Tax withholding / forfeiture | Common Stock | 32,933 | $51.42 | $1.69M | |
| Kim Kelderman - Officer | Option exercise | Stock Option (Right to Buy) | 36,132 | $0.00 | - | |
| John L. Higgins - Director | Option exercise | Common Stock | 12,000 | $21.84 | $262K | |
| John L. Higgins - Director | Option exercise | Stock Options (Right to Buy) | 12,000 | $0.00 | - | |
| William Geist - Officer | Option exercise | Common Stock | 9,912 | $0.00 | - | |
| William Geist - Officer | Tax withholding / forfeiture | Common Stock | 3,270 | $75.31 | $246K | |
| William Geist - Officer | Option exercise | Restricted Stock Units | 9,912 | $0.00 | - | |
| Kim Kelderman - Officer | Tax withholding / forfeiture | Common Stock | 2,430 | $75.31 | $183K | |
| James Hippel - Officer | Option exercise | Common Stock | 13,159 | $0.00 | - | |
| James Hippel - Officer | Tax withholding / forfeiture | Common Stock | 6,475 | $75.31 | $488K | |
| James Hippel - Officer | Option exercise | Restricted Stock Units | 13,159 | $0.00 | - | |
| James Hippel - Officer | Grant or award | Restricted Stock Units | 34,634 | $0.00 | - | |
| Judith V. Klimovsky - Director | Grant or award | Common Stock | 1,462 | $0.00 | - | |
| Judith V. Klimovsky - Director | Grant or award | Stock Option (Right to Buy) | 3,511 | $0.00 | - | |
| Alpna Seth - Director | Grant or award | Common Stock | 1,462 | $0.00 | - | |
| Alpna Seth - Director | Grant or award | Stock Options (Right to Buy) | 3,511 | $0.00 | - |
Item 5.07, 7.01, 9.01
Item 8.01
Item 2.02, 8.01, 9.01
Item 1.01, 5.02, 9.01
Recent TECH Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
Stock trades in TECH disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 April McClain DelaneyDemocrat, MD-06 | Sale |
TECH insider trading FAQ
What is the latest insider trade for TECH?
BIO-TECHNE Corp (TECH) had 17 insider filings in the last 90 days, with the most recent on 2026-09-30. The full record for TECH runs to 66 Form 4 filings, the earliest from 2024-10-28. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TECH stock?
No insider purchases of TECH were filed in the last 90 days.
How many insiders are selling TECH stock?
No insider sales of TECH were filed in the last 90 days. 4 sales are on record for this company.
Where can I see TECH SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TECH Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - John L. Higgins view on EDGAR
- - Robert V. Baumgartner view on EDGAR
- - Shane Bohnen view on EDGAR
- - Kim Kelderman view on EDGAR
- - James Hippel view on EDGAR
- - Amy E. Herr view on EDGAR
- - William Geist view on EDGAR
- - Steven C. Crouse view on EDGAR
- - Kim Kelderman view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where TECH's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TECH with a 7-day demo
- TECH on your watchlist
- Every TECH Form 4 filing on record
- Up to 3 months of TECH price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
